Kathi Niffenegger - Nov 2, 2022 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role: Chief Financial Officer
Signature: /s/ Kathi Niffenegger
Stock symbol: EDSA
Transactions as of: Nov 2, 2022
Transactions value $: $9,999
Form type: 4
Date filed: 11/4/2022, 03:27 PM
Previous filing: Mar 7, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EDSA	Common Shares	Award	$10K	+8.89K	+486.48%	$1.13	10.7K	Nov 2, 2022	By Trust	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EDSA	Common Share Warrants (Right to Buy)	Award		+4.44K			4.44K	Nov 2, 2022	Common Shares	4.44K	$1.50	By Trust	F1, F2
transaction	EDSA	Common Share Warrants (Right to Buy)	Award		+4.44K			4.44K	Nov 2, 2022	Common Shares	4.44K	$1.00	By Trust	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are included within 8,888 Common Shares purchased by the reporting person for $1.1250 per Common Share. Each Common Share includes the purchase of one-half of a Class A Warrant to purchase one Common Share, and one-half of a Class B Warrant to purchase one Common Share.
F2	Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable on the date that is the earlier to occur of 60 days from the closing date of the offering and the date a Registration Statement covering the resale of the Common Shares and Common Shares issuable upon exercise of the Warrants is declared effective (the "Initial Exercise Date") and will expire three years after the Initial Exercise Date.
F3	Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable on the Initial Exercise Date and will expire 12 months after the Initial Exercise Date.